Novavax to Make Restructuring Changes, Reduce Workforce by 25% to Cut Expenses
Novavax will be letting go 25 percent of its workforce in an effort to cut expenses and consolidate facilities and infrastructure. The biotech company plans to trim next year’s costs for research and development, as well as selling, general and administrative expenses by about 40 to 50 percent, compared with 2022. This follows Novavax’s first-quarter […]